Global Vaccine Market Rises to the TopAgain

　　The global vaccine market is a blue oceanin 2021. New coronavirus vaccine leads the market, human papillomavirusvaccine, pneumonia vaccine and influenza vaccine grow steadily. Affected by theepidemic, the public's awareness of vaccines has undergone a major shift,making the vaccination rate of second-tier vaccines show a continuous climb.Comprehensive data from the annual reports of pharmaceutical companies showthat the sales of the top 10 global vaccine manufacturers exceeded USD 100billion in 2021, an increase of more than 300% year-on-year, and vaccines havebeen pushed to the forefront under the competition of new coronavirus productdevelopment, and as more and more anti-new coronavirus drugs hit the market,vaccines will gradually fall back into a normal trajectory.

　　Pfizer, Merck, Sanofi and GSK among thetop 10 global vaccine producers in 2021 are still the old playmakers in R&Dand production, in addition to Germany's BioNTech, U.S. Moderna Biotechnology(Moderna), AstraZeneca and Johnson & Johnson, and China's KexingBiologicals and Jiffy Biologicals have also seized the opportunity. 2021 Amongthe TOP 5 brands in the global new crown vaccine major market, Pfizer occupies40.07%, Germany's Baintech occupies 24.49%, the U.S. Moderna occupies 19.25%,China's Kexing Bio occupies 9.23%, and AstraZeneca occupies 4.36%. According tothe data, China's vaccine market size exceeds 76 billion yuan in 2021, withclass II vaccines occupying 95% of the market size and a compound annual growthrate of 29.1% in the past five years.